312 results on '"Cox, Jafna"'
Search Results
2. Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial
3. Resource use and cost associated with computerized decision support system and usual care in managing patients with atrial fibrillation: analysis of IMPACT-AF randomized trial data
4. Correction: Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care
5. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
6. Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians
7. Temporal Trends in Population Rates of Incident Atrial Fibrillation and Atrial Flutter Hospitalizations, Stroke Risk, and Mortality Show Decline in Hospitalizations
8. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
9. Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care
10. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation
11. Recommandations canadiennes pour les pratiques optimales de soins de l'AVC, septieme edition : l'acide acetylsalicylique pour la prevention d'evenements vasculaires
12. Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events
13. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
14. Where you Live in Nova Scotia Can Significantly Impact Your Access to Lifesaving Cardiac Care: Access to Invasive Care Influences Survival
15. Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile
16. Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)
17. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines
18. Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome
19. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
20. The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients
21. Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry*
22. The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
23. Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences
24. Depression and Disease Severity in Patients with Premature Acute Coronary Syndrome
25. Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada
26. Abstract 16633: Rates and Patterns of Inappropriate Dosing for Non-vitamin K Oral Anticoagulant Among Canadian Atrial Fibrillation Patients: Insights From a Prospective Registry
27. Abstract 16503: Adequacy of Hypertension Control Among Patients With Atrial Fibrillation at High Cardiovascular Risk: Insights From a Canadian Prospective Registry
28. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)
29. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
30. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter
31. Quality indicators for cardiac care: national standards in a community context
32. CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
33. Secular trends in acute coronary syndrome hospitalization from 1994 to 2005
34. Differences Between Perspectives Of Physicians And Patients On Anticoagulation In Patients With Atrial Fibrillation: Observational Study
35. Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: Data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry
36. The effect of place of residence on access to invasive cardiac services following acute myocardial infarction
37. Cardiovascular outcomes after a change in prescription policy for Clopidogrel
38. The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study
39. The impact of warfarin use on clinical outcomes in atrial fibrillation: A population-based study
40. Quality indicators for cardiovascular primary care
41. Trends in event rate and case fatality of patients hospitalized with myocardial infarction between 1984 and 2001 (1)
42. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project
43. Use of complementary and alternative medical therapies in patients with cardiovascular disease
44. Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock
45. Improved prediction of early-onset coronary artery disease using APOE ε4, BChE-K, PPARγ2 Pro12 and ENOS T-786C in a polygenic model
46. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery
47. The potential economic impact of restricted access to angiotensin-receptor blockers
48. Use of Administrative Data to Monitor Cardiac Implantable Electronic Device Complications
49. Use and Impact of Registries for Myocardial Infarction on Process of Care and Outcomes: Examples from Canada
50. Long-term trends in use of and expenditures for cardiovascular medications in Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.